NEW BRUNSWICK, N.J. - Johnson & Johnson will take an 18.4 percent stake in Ireland-based drug developer Elan Corp. with a $1 billion investment.
Copyright PHILY - Philly.com
NEW BRUNSWICK, N.J. - Johnson & Johnson will take an 18.4 percent stake in Ireland-based drug developer Elan Corp. with a $1 billion investment.